Nilsine Partners’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$578K Buy
6,835
+93
+1% +$7.5K 0.04% 289
2026
Q1
$524K Buy
6,742
+354
+6% +$26.5K 0.04% 279
2025
Q4
$504K Buy
6,388
+154
+2% +$12.2K 0.04% 276
2025
Q3
$513K Buy
6,234
+325
+6% +$25.6K 0.05% 271
2025
Q2
$475K Sell
5,909
-12
-0.2% -$926 0.05% 264
2025
Q1
$475K Sell
5,921
-216
-4% -$18K 0.05% 251
2024
Q4
$502K Buy
6,137
+1,969
+47% +$164K 0.05% 257
2024
Q3
$344K Buy
4,168
+175
+4% +$13.1K 0.04% 266
2024
Q2
$280K Sell
3,993
-37
-0.9% -$2.64K 0.04% 286
2024
Q1
$299K Sell
4,030
-126
-3% -$8.78K 0.04% 283
2023
Q4
$275K Sell
4,156
-3,288
-44% -$206K 0.04% 273
2023
Q3
$468K Buy
7,444
+2
+0% +$125 0.07% 237
2023
Q2
$421K Sell
7,442
-2,077
-22% -$115K 0.06% 251
2023
Q1
$552K Buy
+9,519
New +$642K 0.09% 216

Other funds holding MET

Nilsine Partners's MET Position: Q2 2026 in Review

Nilsine Partners increased its MetLife (MET) stake by 1.4% in Q2 2026, buying an estimated $7.5K and bringing the position to 6,835 shares worth $578K. The position accounts for 0.04% of the portfolio, ranked #289.

Nilsine Partners first reported a position in MET in Q1 2023 and has held it in 14 quarters since. 423 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Nilsine Partners held 6,835 shares of MetLife worth $578K as of Q2 2026.
  • Nilsine Partners bought 93 MetLife shares in Q2 2026, an estimated $7.5K.
  • MetLife made up 0.04% of Nilsine Partners's portfolio in Q2 2026, its #289 holding.
  • Nilsine Partners first reported a position in MetLife in Q1 2023 and has held it in 14 quarters since.
  • 423 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Nilsine Partners's 13F filing for Q2 2026, filed 24 Jul 2026.